A detailed history of Baillie Gifford & CO transactions in Schrodinger, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,980,992 shares of SDGR stock, worth $42.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,980,992
Previous 2,124,968 6.78%
Holding current value
$42.9 Million
Previous $41.1 Million 10.58%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$18.05 - $24.02 $2.6 Million - $3.46 Million
-143,976 Reduced 6.78%
1,980,992 $36.7 Million
Q2 2024

Jul 25, 2024

SELL
$18.65 - $28.5 $9.08 Million - $13.9 Million
-487,039 Reduced 18.65%
2,124,968 $41.1 Million
Q1 2024

May 01, 2024

BUY
$24.74 - $35.13 $237,949 - $337,880
9,618 Added 0.37%
2,612,007 $70.5 Million
Q4 2023

Jan 26, 2024

SELL
$21.62 - $37.21 $7.53 Million - $13 Million
-348,163 Reduced 11.8%
2,602,389 $93.2 Million
Q3 2023

Nov 13, 2023

SELL
$27.34 - $55.37 $431,944 - $874,790
-15,799 Reduced 0.53%
2,950,552 $83.4 Million
Q2 2023

Jul 28, 2023

BUY
$26.1 - $49.92 $17.8 Million - $34 Million
681,500 Added 29.83%
2,966,351 $148 Million
Q1 2023

May 03, 2023

BUY
$18.09 - $27.61 $8.38 Million - $12.8 Million
462,993 Added 25.41%
2,284,851 $60.2 Million
Q4 2022

Jan 24, 2023

BUY
$16.24 - $26.38 $10.4 Million - $16.9 Million
640,051 Added 54.16%
1,821,858 $34.1 Million
Q3 2022

Oct 27, 2022

SELL
$23.95 - $34.71 $1.74 Million - $2.52 Million
-72,629 Reduced 5.79%
1,181,807 $29.5 Million
Q2 2022

Aug 08, 2022

SELL
$21.39 - $35.9 $179,996 - $302,098
-8,415 Reduced 0.67%
1,254,436 $33.1 Million
Q1 2022

May 05, 2022

BUY
$24.84 - $36.12 $31.4 Million - $45.6 Million
1,262,609 Added 521739.25%
1,262,851 $43.1 Million
Q1 2021

May 06, 2021

BUY
$64.61 - $113.09 $1,098 - $1,922
17 Added 7.56%
242 $18,000
Q4 2020

Feb 10, 2021

BUY
$48.06 - $84.4 $10,813 - $18,990
225 New
225 $18,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.34B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.